Ryan Glosier

Ryan Glosier

Benzinga Staff Writer

About
Benzinga has allowed me a tremendous platform to explore my passions for trading, investing, startups and venture capital over the years. I was one of the company’s very first employees when Jason Raznick was launching the now ubiquitous financial me...
The Usual Suspects Lead Market Higher Early Thursday – Where To Find Potential Outsized Gains
How To Trade The Whistleblower Revelations About UFOs
Bombshell Whistleblower Testimony Suggests Virgin Galactic Could Be Wildly Undervalued
Has The Early Weakness In Energy Names Been Erased?
Is This The Most Wildly Bullish Chart On The NASDAQ?
Have Poor Q1 Earnings Set Up A Short Opportunity In These Two Brick-And-Mortar Retailers?
Bill Miller IV Isn't Chasing Nvidia In Its $1-Trillion Days: 2 Stock Ideas From The Money Manager
Trading Regional Banks – Is The Crisis Really Over?
How To Trade Nvidia This Week
Short Sellers Are Still Targeting Brick-And-Mortar Retailers – Should You Too? A Look At DDS And GME
Regional Banks Remain On Life Support
Value Investing: Three Dirt Cheap Stocks
Drug Data Sends ImmunoGen (NASDAQ: IMGN) To Multi-Year Highs, Up 150% In Two Days
Wolfspeed Technical Outlook After Last Thursday's Big Plunge – The Drop Continues
Meta Platforms Technical Outlook: A Checkered Flag? Stock Seems Set Up For Continued Run
Three Swing-Trade Shorts With Significant Catalysts
3 Long-Term Brand Bets With A Great Track Record That Display Significant Potential
Potential Breakout Setups To Watch On Wednesday
Semiconductors And Consumer Cyclical Stocks Lead Tuesday's Sell-Off; Stocks To Watch Wednesday
Looking For Shorts? Check Out This List Of Names Exhibiting Significant Weakness